The Roche LightCycler® MRSA Advanced Test offers a simple, flexible and reliable way to incorporate molecular MRSA surveillance into your hospital's infection control program today. Based on Roche's proven LightCycler® platform, which has set the standard for real-time PCR for more than a decade, the LightCycler® MRSA Advanced Test combines cutting-edge technologies with 20 years of expertise and dedication to molecular diagnostics.
- Ensure the safety and productivity of laboratory staff.
Simple sample preparation without pipetting steps minimizes the risk of repetitive strain injuries.
- Ready-to-use convenience.
Provided in a ready-to-use format, minimizing hands-on time and the need for specialized skills.
- More power, less space.
Obtain results in 2 hours of laboratory time for batches of 1 to 30 samples. A small instrument footprint makes it easy to incorporate additional LightCycler® Instruments as your testing needs grow.
- Test in small batches, on-demand.
The LightCycler® MRSA Advanced Test improves overall turnaround time without reagent waste or significant cost increase no matter what your batch size.
- Increase your throughput.
Test 30 samples per batch size without exponentially increasing hands-on time and cost. Run up to 40,000 tests per year on a single instrument (single shift, 5 days a week).
- Validated for use with 3 swab transport media.
- High diagnostic sensitivity and specificity.
A clinical trial in the US in 2008/2009 involving more than 1,400 patient samples from 5 different sites, covering different geographical regions, compared the LightCycler® MRSA Advanced Test performance to directly plated culture on a chromogenic media and to a second NAT-based test.
Preliminary analysis revealed that the LightCycler® MRSA Advanced Test is likely to deliver diagnostic sensitivity and specificity greater than 96% against chromogenic culture.
- More accurate and reliable.
The LightCycler® MRSA Advanced Test is the only rapid MRSA test containing the Roche AmpErase enzymes that reduce post-amplification contamination.
How is your hospital responding to the increasing demand for better infection control?
In an effort to reduce the colonization / infection rates, negative healthcare outcomes, and overall costs associated with MRSA, many local, regional, and national authorities are recommending and in some cases requiring more aggressive screening, documentation, and reporting of MRSA.
The LightCycler® MRSA Advanced Test is a qualitative in vitro diagnostic test for the direct detection of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA infections in healthcare settings. The test is performed on the LightCycler® 2.0 Instrument with nasal swab specimens from patients suspected of colonization, uses swab extraction and mechanical lysis for specimen preparation followed by polymerase chain reaction (PCR) for the amplification of MRSA DNA, and fluorogenic target specific hybridization probes for the detection of the amplified DNA. The LightCycler® MRSA Advanced Test is not intended to diagnose MRSA infections nor to guide or monitor treatment for MRSA infections. Concomitant cultures are necessary only to recover organisms for epidemiology typing or for further susceptibility testing.
|LightCycler® MRSA Advanced Test
|LightCycler® Advanced Lysis Kit
Rely on Roche for better healthcare and patient management.
Read more about the LightCycler® 2.0 Instrument